Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Analysis of patent CN105777461A reveals a high-yield Pd-Cu catalytic route for phenanthrene derivatives offering significant supply chain stability and cost optimization.
Patent CN109776506B details a novel 10-step synthesis of chiral (-)-cephalotaxine from furan. Discover cost-effective manufacturing and supply chain advantages.
Discover a novel metal-free synthesis method for 3-acyl indoles via nucleophilic organocatalysis. Achieve high purity and cost reduction in API manufacturing with scalable processes.
Novel synthesis route for HCV intermediate reduces cost and improves purity for pharmaceutical supply chains. Efficient scalable production of high-purity antiviral drug intermediates ensures reliable global supply continuity.
Patent CN105879905A introduces a novel chiral phosphine catalyst enabling high enantioselectivity in cross Rauhut-Currier reactions, offering significant supply chain and cost advantages.
Patent CN104447376A details a low-cost Chlorambucil synthesis route offering significant supply chain stability and cost reduction in API manufacturing for global partners.
Patent CN102399165B reveals a high-yield Chloramphenicol synthesis using nitromethane, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN112979580A reveals a metal-free visible light method for alkylbenzothiazoles, offering green synthesis and cost reduction for pharma intermediates.
Patent CN1149192C details a scalable Raney Nickel route for quinolone intermediates, eliminating hazardous reagents and improving purity for reliable API supplier partnerships.
Patent CN110372544A reveals low-cost iron-titanium catalysis for biaryl synthesis. Achieve significant cost reduction and supply chain reliability in pharmaceutical intermediate manufacturing.
Patent CN111072720B reveals a metal-free photocatalytic route for phosphono-heterocycles, offering significant cost reduction and supply chain reliability for pharma intermediates.
Patent CN109851634B discloses Yu-Phos ligands for asymmetric catalysis. Enables cost reduction in pharmaceutical intermediate manufacturing with high stereoselectivity.
Patent CN107602357B details a solvent-free catalytic method for converting isopulegol to menthone. This breakthrough offers significant cost reduction in flavor and fragrance manufacturing through high-efficiency homogeneous catalysis.
Novel Lewis acid catalyzed reductive amination route offers >99% purity and scalable production for pharmaceutical intermediates.
Patent CN120647657A reveals metal-free visible light synthesis for sulfonylated benzazepine indolones. Enables cost reduction and scalable supply for pharmaceutical intermediates.
Patent CN115724783A reveals a novel furfural-based route for asymmetric cyanine dyes, offering superior regioselectivity and cost reduction in biomedical material manufacturing.
Patent CN111138350B reveals a high-yield asymmetric synthesis route for dexchlorpheniramine, offering significant cost reduction and supply chain reliability for API manufacturers.
Patent CN114107236B reveals a high-efficiency ketoreductase mutant for synthesizing Ibrutinib intermediates, offering superior yield and scalability for pharmaceutical manufacturing.
Novel transition-metal-free route for 2-aryl acetophenones. Reduces cost and improves supply chain reliability for pharmaceutical intermediates manufacturing.
Advanced solid-acid catalyzed synthesis of Ginsenoside Rh3 from Protopanaxadiol. Delivers high stereoselectivity and cost reduction in pharmaceutical intermediates manufacturing.